HRTX — HERON THERAPEUTICS, INC. /DE/
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on HRTX
| date | signal | measured base rate |
|---|---|---|
| 2026-06-11 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-06 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-06 | Hensley Mark Earl Chief Operating Officer | Shares withheld for tax | 8.9K | 0.50 | 4.4K |
| 2026-08-06 | Hensley Mark Earl Chief Operating Officer | Option exercise | 31.2K | — | — |
| 2026-07-31 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for tax | 3.3K | 0.50 | 1.7K |
| 2026-07-31 | Forbes William P EVP, Chief Development Officer | Shares withheld for tax | 3.3K | 0.50 | 1.7K |
| 2026-07-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise | 11.7K | — | — |
| 2026-07-31 | Collard Craig A Chief Executive Officer | Option exercise | 34.8K | — | — |
| 2026-07-31 | Forbes William P EVP, Chief Development Officer | Option exercise | 11.7K | — | — |
| 2026-07-31 | Hensley Mark Earl Chief Operating Officer | Option exercise | 11.8K | — | — |
| 2026-07-30 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for tax | 3.9K | 0.50 | 1.9K |
| 2026-07-30 | Forbes William P EVP, Chief Development Officer | Shares withheld for tax | 3.3K | 0.50 | 1.7K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Rubric Capital Management LP | 24.0M | 30.0M |
| Clearline Capital LP | 9.8M | 12.2M |
| BlackRock, Inc. | 8.1M | 10.1M |
| ORBIMED ADVISORS LLC | 7.9M | 9.8M |
| Velan Capital Investment Management LP | 7.0M | 8.8M |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.2M | 7.8M |
| MILLENNIUM MANAGEMENT LLC | 6.1M | 7.6M |
| Tejara Capital Ltd | 5.1M | 6.3M |
| TANG CAPITAL MANAGEMENT LLC | 5.0M | 6.2M |
| PALISADE CAPITAL MANAGEMENT, LP | 4.9M | 6.1M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Heron Therapeutics, Inc. /de/ (HRTX) filed form 8-K · 2026-08-14 · SEC EDGAR
Ask the AI about HRTX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →